Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Bando Chemical Industries Ltd. ( (JP:5195) ) is now available.
Bando Chemical Industries, Ltd. announced significant financial adjustments for the fiscal year ended March 31, 2025, due to impairment losses and a decline in the valuation of shares in subsidiaries and affiliates. The company recorded an impairment loss of ¥5,035 million, primarily due to delays in FDA approval affecting its subsidiary Aimedic MMT Co., Ltd., and decreased profitability in its Advanced Elastomer Products Business. Additionally, a loss of ¥4,049 million was recorded on the valuation of shares, with notable declines in the value of shares in Aimedic MMT Co., Ltd. and Bando USA, Inc. These financial adjustments have led to a downward revision of the company’s consolidated financial results forecast, with operating profit and profit attributable to owners expected to be lower than previously anticipated.
More about Bando Chemical Industries Ltd.
Bando Chemical Industries, Ltd. operates within the chemical industry, focusing on manufacturing and distributing a range of chemical products. The company is known for its advanced elastomer products and has a significant presence in the market for industrial and automotive components.
Average Trading Volume: 39,598
Technical Sentiment Signal: Hold
Current Market Cap: Yen62.2B
For an in-depth examination of 5195 stock, go to TipRanks’ Stock Analysis page.